Akebia Therapeutics, Inc. (AKBA)
0.9043
-0.05
(-5.64%)
USD |
NASDAQ |
Aug 26, 16:00
0.9043
0.00 (0.00%)
After-Hours: 19:30
Akebia Therapeutics Total Return Level : 0.9584 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 0.9584 |
| August 24, 2026 | 0.9006 |
| August 21, 2026 | 0.9066 |
| August 20, 2026 | 0.9194 |
| August 19, 2026 | 0.8854 |
| August 18, 2026 | 0.8518 |
| August 17, 2026 | 0.86 |
| August 14, 2026 | 0.8728 |
| August 13, 2026 | 0.8696 |
| August 12, 2026 | 0.8932 |
| August 11, 2026 | 0.8665 |
| August 10, 2026 | 0.844 |
| August 07, 2026 | 0.9099 |
| August 06, 2026 | 0.9544 |
| August 05, 2026 | 1.29 |
| August 04, 2026 | 1.32 |
| August 03, 2026 | 1.31 |
| July 31, 2026 | 1.32 |
| July 30, 2026 | 1.35 |
| July 29, 2026 | 1.26 |
| July 28, 2026 | 1.27 |
| July 27, 2026 | 1.28 |
| July 24, 2026 | 1.22 |
| July 23, 2026 | 1.22 |
| July 22, 2026 | 1.26 |
| Date | Value |
|---|---|
| July 21, 2026 | 1.30 |
| July 20, 2026 | 1.28 |
| July 17, 2026 | 1.34 |
| July 16, 2026 | 1.40 |
| July 15, 2026 | 1.38 |
| July 14, 2026 | 1.40 |
| July 13, 2026 | 1.38 |
| July 10, 2026 | 1.40 |
| July 09, 2026 | 1.43 |
| July 08, 2026 | 1.42 |
| July 07, 2026 | 1.36 |
| July 06, 2026 | 1.30 |
| July 02, 2026 | 1.24 |
| July 01, 2026 | 1.21 |
| June 30, 2026 | 1.14 |
| June 29, 2026 | 1.11 |
| June 26, 2026 | 1.14 |
| June 25, 2026 | 1.04 |
| June 24, 2026 | 1.06 |
| June 23, 2026 | 1.10 |
| June 22, 2026 | 1.09 |
| June 18, 2026 | 1.07 |
| June 17, 2026 | 1.02 |
| June 16, 2026 | 0.984 |
| June 15, 2026 | 0.9387 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Emergent BioSolutions, Inc. | 5.64 |
| Exelixis, Inc. | 56.72 |
| ADMA Biologics, Inc. | 9.72 |
| Arcutis Biotherapeutics, Inc. | 24.86 |
| Relay Therapeutics, Inc. | 20.57 |